Intellectual Property · Strategy
Trade Secrets vs Patents
A patent expires in 20 years and requires full public disclosure. A trade secret lasts forever — but only until a competitor independently discovers it or reverse-engineers your product. Here's the decision framework, how the DTSA works, and when each form of protection wins.
The core distinction
A patent stops even independent discovery. A trade secret does not — the moment a competitor reverse-engineers your product or independently invents the same thing, trade secret protection is gone. If your product can be reverse-engineered, a patent is almost always the stronger choice.
Head-to-head comparison
Patent vs trade secret: 8 key differences
When to patent
5 situations where a patent is stronger
Product can be reverse-engineered
If a competitor can buy your product off the shelf and engineer it backwards to figure out how it works, trade secret protection evaporates the moment it ships. A patent protects even against independently derived discoveries.
You need to disclose to commercialize
Licensing requires explaining the technology; investor pitches require explanation; manufacturing partnerships require explanation. Each disclosure risks the secret. A patent lets you disclose freely without losing protection.
20-year exclusivity is sufficient
For most consumer products, software, medical devices — market timelines are 5–15 years. A 20-year patent monopoly covers the full commercial life of the product.
You want to exclude competitors legally
Only a patent gives you a right to exclude others regardless of how they arrived at the same invention. Trade secrets don't reach independent discovery.
IP is a core asset for fundraising
Patents on the cap table signal defensibility and command higher valuations. Trade secrets are harder to audit, transfer, and assign. Acquirers often require patents for M&A diligence.
When to keep it secret
5 situations where trade secret wins
Method that can't be reverse-engineered
Coca-Cola's formula, KFC's seasoning blend — internal manufacturing processes that competitors cannot reverse-engineer from the final product. The recipe stays secret forever, not just 20 years.
Incremental improvements with short competitive advantage
Continuous process optimizations where the competitive value evaporates before a patent would issue (2–3 years). A trade secret keeps you ahead without teaching competitors via the published patent.
Algorithm or model trained on proprietary data
An ML model's architecture might be patentable, but the model itself (weights, hyperparameters, training data composition) is protected as a trade secret. Often companies patent the training method and keep the trained model as a secret.
Customer lists, pricing formulas, market analyses
These categories don't meet patent eligibility requirements but can be powerful trade secrets — as long as they meet the DTSA's reasonable secrecy measures requirement and derive value from being secret.
When patent prosecution is too slow
For a market window of 12–18 months, a patent (2–3 year pendency) offers little value. Trade secret protection is immediate. Pair with speed-to-market as your primary defense.
Federal law · 2016
How the Defend Trade Secrets Act works
The DTSA (18 U.S.C. §§ 1836–1839), enacted May 2016, was the first federal civil cause of action for trade secret misappropriation. Before it, trade secret law was state-only — most states had adopted the Uniform Trade Secrets Act (UTSA) but definitions and remedies varied. Now, companies can sue in federal court directly under the DTSA while still pleading state UTSA claims.
DTSA definition of 'trade secret'
Information — including formulas, programs, methods, techniques, financial data, business plans — that: (1) derives independent economic value from not being generally known or readily ascertainable; and (2) has been subject to reasonable measures to maintain secrecy.
What counts as misappropriation
Acquisition by improper means (theft, bribery, misrepresentation, electronic espionage, breach of duty); or disclosure/use of a secret obtained by improper means or under a duty of confidentiality. NOT misappropriation: independent discovery, reverse engineering, or publicly available info.
Remedies under the DTSA
Injunctive relief; compensatory damages (actual loss + unjust enrichment from misappropriation); exemplary damages up to 2× for willful/malicious misappropriation; attorney's fees for willful/malicious misappropriation or bad-faith claims.
Ex parte seizure provision
Unique to the DTSA: courts can order pre-hearing seizure of misappropriated trade secrets when immediate irreparable injury would occur, the defendant has possession, and alternative remedies are inadequate. An extraordinary remedy rarely granted.
FAQ
Trade secret questions
What is the Defend Trade Secrets Act (DTSA)?
The Defend Trade Secrets Act (DTSA), enacted in May 2016 (18 U.S.C. §§ 1836–1839), created a federal civil cause of action for trade secret misappropriation for the first time in US history. Before the DTSA, trade secret law was entirely state-based — most states had adopted the Uniform Trade Secrets Act (UTSA), but the laws varied and there was no federal court jurisdiction without diversity of citizenship. The DTSA: (1) defines trade secret broadly as information (including formulas, patterns, programs, devices, methods, techniques, processes, financial and business information) that (a) derives independent economic value from not being generally known, and (b) has been subject to reasonable measures to keep it secret; (2) defines misappropriation as acquisition by improper means (theft, bribery, espionage, breach of confidence), or disclosure/use without consent of information acquired by improper means; (3) provides remedies of injunctive relief, compensatory damages, exemplary damages (up to 2×) for willful/malicious misappropriation, and attorney's fees; (4) includes a unique ex parte seizure provision allowing a court to order seizure of misappropriated trade secrets before a hearing — an extraordinary remedy; (5) preempts state law to some extent but does not replace UTSA claims — plaintiffs often plead both DTSA and state UTSA claims.
What is the key difference between patent protection and trade secret protection?
The most important practical difference: a patent protects against independent discovery; a trade secret does not. If a competitor independently invents the same thing — without any access to your secret — a patent lets you sue them for infringement, but a trade secret gives you no remedy at all. Conversely, a trade secret lasts indefinitely (as long as the secret is maintained), while a patent expires in 20 years (utility) after which the invention enters the public domain. A patent requires full disclosure — your specification must teach the public how to make and use the invention. A trade secret requires no disclosure and keeps the information private. The key question: can a competitor reverse-engineer your product to figure out the secret? If yes, trade secret protection is fragile and a patent is usually better. If no (e.g., an internal manufacturing process, a proprietary algorithm embedded in a black-box system), trade secret may outlast a patent. Another difference: patents are national — you must file separately in each country where you want protection. Trade secrets are global by default, though enforcement in other countries depends on local law.
What qualifies as a trade secret under the DTSA?
Under the Defend Trade Secrets Act, information qualifies as a trade secret if it meets two requirements: (1) Independent economic value from secrecy: the information derives actual or potential economic value from not being generally known to or readily ascertainable by other persons who could obtain economic value from its disclosure or use. This means the information gives a competitive advantage because it's secret — not because it's inherently superior. (2) Reasonable measures to keep it secret: the owner has taken reasonable measures to maintain the secrecy of the information. 'Reasonable measures' is fact-specific but generally includes: marking confidential documents as confidential; using NDAs with employees, contractors, and business partners; limiting access to people who need to know; physical and digital security measures; exit interviews when employees depart; enforcing secrecy consistently. A company that freely shares information, fails to use NDAs, or takes no steps to protect secrecy may find its 'trade secret' isn't legally protected. Common trade secrets: formulas and recipes (Coca-Cola); source code; customer lists and pricing; manufacturing processes; marketing strategies; financial projections; algorithms and models. Information that is generally known, readily ascertainable through reverse engineering of a public product, or independently discovered does not qualify.
Can you use both patent protection and trade secret protection for the same invention?
Not for the exact same information — a patent requires full public disclosure, which destroys trade secret protection for the disclosed subject matter. However, you can use patents and trade secrets strategically on different aspects of the same technology. Common hybrid approach: (1) Patent the method or process — the mechanism of how it works, which teaches the field and captures the core innovation for 20 years; (2) Keep the implementation details as trade secrets — the specific trained model weights, the particular hyperparameters, the exact training data composition, the manufacturing tolerances — details that are valuable, not fully disclosed by the patent, and hard to reverse-engineer; (3) Use trade secrets for complementary know-how — process expertise, quality control methods, supplier relationships — that surrounds the patented technology. Example: an AI company might patent the training method (publicly teaching the approach) while keeping the trained model (weights, data) as a trade secret. The patent deters someone from using the same training approach; the trade secret protects the specific implementation advantage. Note: an 'on-sale bar' issue can arise — if you sell a product commercially for more than one year before filing a patent application, the patent may be barred under § 102(b)(1)(A). Choosing trade secret protection and then switching to patent protection later can forfeit patent rights if the commercial use was too long before filing.
When should a startup choose trade secret protection over a patent?
A startup should seriously consider trade secret protection instead of or alongside patents when: (1) The competitive advantage is in a method that cannot be reverse-engineered from the product — an internal manufacturing process, a data pipeline, a training methodology — where competitors cannot lawfully derive the secret from the market-facing product; (2) The competitive advantage has a short market window — if your product will be obsolete in 18 months, a 2–3 year patent prosecution timeline means your patent issues after your market advantage is gone. Trade secret protection is immediate; (3) Incremental innovations that don't meet the patent bar individually — continuous process improvements that collectively give you a cost or quality advantage but don't individually support patent claims; (4) Cost constraints — a serious trade secret program costs far less than $15,000–$60,000+ in patent prosecution fees; for very early-stage startups, protecting core know-how with NDAs and internal security until they can afford patents is practical; (5) Data assets — customer data, proprietary datasets, trained models — that are not independently patentable but represent enormous competitive value. Caution: investors and acquirers often prefer patents to trade secrets for IP valuation in M&A; and trade secrets provide no protection against independent development by well-resourced competitors. The best strategy often combines both: patent the core novel mechanism, use trade secrets for surrounding know-how.